Short answer
Lexeo Therapeutics, Inc. (LXEO) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events). Item 2.02 filing language contains only an incorporation-by-reference disclaimer.
Lexeo Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 filing language contains only an incorporation-by-reference disclaimer
- No earnings period, financial results, or operating metrics disclosed in the provided text
Item 8.01 · Other Events
- Updated corporate presentation posted May 11, 2026 for investor and analyst meetings
- Exhibit 99.2 contains company messaging and disclosures relevant to investor assessment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Lexeo Therapeutics, Inc. 8-K filings
Get the next LXEO 8-K as it lands
Follow LXEO for push alerts, or ask the research agent what this filing means.